Loxo Oncology: latest news - GoINPHARMA
Tuesday, 11 December 2018 - 23:34

Loxo Oncology

Recent progress in oncology

The FT has published today, on the occasion of the ASCO congress opening, a complex report about recent medicine progress in the fight against cancer. The area with most research activity and trials is immunotherapy, which generated sales of $3.2bn…

xo Oncology trading leader (+23%) following results of clinical trial

Loxo Oncology’s shares yesterday soared by 23% (Nasdaq) as the company published an abstract of the presentation prepared for the ASCO (American Society for Clinical Oncology) Annual Meeting, to be held from 1 to 5 June.  The presentation includes preliminary…

Loxo Oncology dominates Nasdaq thanks to robust Phase III results

Shares of US-based Loxo Oncology increased by over 50% (NASDAQ) as new clinical data showed that the approach chosen by Loxo to treat cancer is successful. Loxo’s treatment strategy is based on focusing on specific genetic defects causing tumors, independently…